Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.

The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden ...

Zilovertamab vedotin plus R-GemOx showed a 56.3% objective response rate in relapsed/refractory DLBCL patients, with a 50% complete response rate at the recommended phase 2 dose. The median duration ...

Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...

Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...